Abstract:Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, caused by a complex interplay of genetic and environmental factors. This study aimed to evaluate the combined efficacy of multi-polygenic risk scores and pooled cohort equations (PCE) for predicting future CVD risks in the Korean population. In this longitudinal study, 7,612 individuals from the Ansan and Ansung cohorts were analyzed over a 17-year follow-up period. The participants were genotyped using the Korea Biobank Array, and quality-controlled genetic data were subjected to imputation analysis. The weighted sum of the PRSs (wPRSsum) was calculated using PRS-CS with summary statistics from myocardial infarction, ischemic stroke, coronary artery disease, and hypertension genome-wide association studies. The recalibrated PCE was used to assess clinical risk, and the participants were stratified into risk groups based on the wPRSsum and PCE. Associations between these risk scores and incident CVD were evaluated using Cox proportional hazards models and Kaplan–Meier analysis. The wPRSsum approach showed a significant association with incident CVD (HR = 1.15, p = 7.49 × 10 −5 ), and the top 20% high-risk genetic group had an HR of 1.50 ( p = 5.04 × 10 −4 ). The recalibrated PCE effectively differentiated between the low and high 10-year CVD risk groups, with a marked difference in survival rates. The predictive models constructed using the wPRSsum and PCE demonstrated a slight improvement in prediction accuracy, particularly among males aged <55 years (C-index = 0.640). We demonstrated that while the integration of wPRSsum with PCE did not significantly outperform the PCE-only model (C-index: 0.703 for combined and 0.704 for PCE-only), it provided enhanced stratification of CVD risk. The highest risk group, identified through the combination of high wPRSsum and PCE scores, exhibited an HR of 4.99 for incident CVD ( p = 1.45 × 10 −15 ). These findings highlight the potential of integrating genetic risk assessments with traditional clinical tools for effective CVD risk stratification. Although the addition of wPRSsum to the PCE provided a marginal predictive improvement, it proved valuable in identifying high-risk individuals and supporting personalized treatment strategies. This study reinforces the utility of multi-PRS in conjunction with clinical risk assessment tools, paving the way for more tailored approaches for CVD prevention and management in diverse populations.

Polygenic risk score model for renal cell carcinoma in the Korean population and relationship with lifestyle-associated factors

Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations

Predicting Lung Cancer in Korean Never-Smokers With Polygenic Risk Scores

Polygenic risk score for tumor aggressiveness and early-onset prostate cancer in Asians

Evaluating the predictive value of genetic risk score in colorectal cancer among Chinese Han population

Risk prediction and interaction analysis using polygenic risk score of type 2 diabetes in a Korean population

Polygenic risk score validation using Korean genomes of 265 early-onset acute myocardial infarction patients and 636 healthy controls

Genetic Scores Based on Risk-Associated Single Nucleotide Polymorphisms (snps) Can Reveal Inherited Risk of Renal Cell Carcinoma

Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases

Evaluating cardiovascular disease risk stratification using multiple-polygenic risk scores and pooled cohort equations: insights from a 17-year longitudinal Korean cohort study

The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population

Stacked neural network for predicting polygenic risk score

Towards Personalized Breast Cancer Risk Management: A Thai Cohort Study on Polygenic Risk Scores

Methodologies underpinning polygenic risk scores estimation: a comprehensive overview

Association between dyslipidemia and the risk of incident chronic kidney disease affected by genetic susceptibility: Polygenic risk score analysis

Polygenic risk scores for prediction of breast cancer risk in Asian populations

Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers

Predictive value of polygenic risk score for prostate cancer incidence and prognosis in the Han Chinese

Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study

Integration of risk factor polygenic risk score with disease polygenic risk score for disease prediction

Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort